Brief: Compugen Presents Preliminary Translational Data Demonstrating Immune Activation in the Tumor Microenvironment by COM701 at the TIGIT Therapies Digital Summit
09/12/2021 12:43
Dec 9 (Reuters) - Compugen Ltd CGEN.TA :
* COMPUGEN PRESENTS PRELIMINARY TRANSLATIONAL DATA
DEMONSTRATING
IMMUNE ACTIVATION IN THE TUMOR MICROENVIRONMENT BY COM701 AT THE
TIGIT THERAPIES DIGITAL SUMMIT
Source text for Eikon: ID:nPn4qDG28a
Further company coverage: CGEN.TA
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025